StoneCo Reports First Quarter 2024 Results
May 13, 2024 16:03 ET
|
StoneCo Ltd.
Adjusted EBT reaching R$568 million, up 75% year over year, on MSMB TPV growth including PIX P2M of 24%, resulting in Adjusted Net income of R$450 million, up 90% year over year GEORGE TOWN, Grand...
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
May 13, 2024 16:03 ET
|
Augmedix Inc
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended...
Stereotaxis Reports 2024 First Quarter Financial Results
May 13, 2024 16:03 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
NAVIOS MARITIME HOLDINGS INC. PROVIDES IMPORTANT REMINDER FOR ALL HOLDERS OF SERIES G AND SERIES H AMERICAN DEPOSITARY SHARES:
May 13, 2024 16:02 ET
|
Navios Maritime Holdings, Inc.
GRAND CAYMAN, Cayman Islands, May 13, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”), today provided a reminder of its previously announced tender offer...
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
May 13, 2024 16:02 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has...
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 13, 2024 16:01 ET
|
Journey Medical Corporation
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a 7%...
Dundee Corporation Declares Quarterly First Preference Shares, Series 2 Dividend
May 13, 2024 16:01 ET
|
Dundee Corporation
TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.B) (“Dundee”) announced today that its board of directors has approved the payment of a quarterly cash dividend of $0.33025...
Dundee Corporation Declares Quarterly First Preference Shares, Series 3 Dividend
May 13, 2024 16:01 ET
|
Dundee Corporation
TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.D) (“Dundee”) announced today that its board of directors has approved the payment of a quarterly cash dividend of $0.56595...
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
May 13, 2024 16:01 ET
|
Vaxart, Inc.
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants ...
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
May 13, 2024 16:01 ET
|
Voyager Therapeutics, Inc.
- Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer’s disease; expect to begin single ascending dose trial in the coming weeks - -...